51
Participants
Start Date
July 6, 2021
Primary Completion Date
April 25, 2024
Study Completion Date
April 25, 2024
Nutritional intervention
Subjects should consume two 200 mL bottles of study product per day next to their cancer treatment (immunotherapy)
Immunotherapy
Pembrolizumab monotherapy with or without combination chemotherapy according to standard of care
Erasmus MC, Rotterdam
Joachim Aerts, MD PhD
OTHER